Document is current
Any future updates will be listed below
-
Authors
Thompson, Scott M. http://orcid.org/0000-0001-9844-9049
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 MH086828)
- License Information
-
More Information
Article History
Received: 14 May 2023
Revised: 14 July 2023
Accepted: 8 August 2023
First Online: 14 September 2023
Competing interests
: The University of Maryland Baltimore has patents, on which I am listed as an inventor, covering the use of α5-selective NAMs to treat psychiatric disease.
